全文获取类型
收费全文 | 126919篇 |
免费 | 9915篇 |
国内免费 | 3613篇 |
专业分类
耳鼻咽喉 | 991篇 |
儿科学 | 2338篇 |
妇产科学 | 1816篇 |
基础医学 | 6994篇 |
口腔科学 | 2870篇 |
临床医学 | 15525篇 |
内科学 | 18860篇 |
皮肤病学 | 2321篇 |
神经病学 | 6432篇 |
特种医学 | 4066篇 |
外国民族医学 | 39篇 |
外科学 | 12433篇 |
综合类 | 18637篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 5353篇 |
眼科学 | 2084篇 |
药学 | 10248篇 |
82篇 | |
中国医学 | 11839篇 |
肿瘤学 | 17494篇 |
出版年
2024年 | 312篇 |
2023年 | 2275篇 |
2022年 | 4162篇 |
2021年 | 5642篇 |
2020年 | 5327篇 |
2019年 | 4675篇 |
2018年 | 4423篇 |
2017年 | 4935篇 |
2016年 | 5251篇 |
2015年 | 5002篇 |
2014年 | 9221篇 |
2013年 | 11432篇 |
2012年 | 7449篇 |
2011年 | 7974篇 |
2010年 | 6617篇 |
2009年 | 5987篇 |
2008年 | 5859篇 |
2007年 | 6295篇 |
2006年 | 5621篇 |
2005年 | 4997篇 |
2004年 | 4045篇 |
2003年 | 3664篇 |
2002年 | 3005篇 |
2001年 | 2651篇 |
2000年 | 2201篇 |
1999年 | 1722篇 |
1998年 | 1422篇 |
1997年 | 1204篇 |
1996年 | 992篇 |
1995年 | 904篇 |
1994年 | 713篇 |
1993年 | 543篇 |
1992年 | 481篇 |
1991年 | 445篇 |
1990年 | 377篇 |
1989年 | 331篇 |
1988年 | 321篇 |
1987年 | 274篇 |
1986年 | 216篇 |
1985年 | 256篇 |
1984年 | 225篇 |
1983年 | 169篇 |
1982年 | 166篇 |
1981年 | 163篇 |
1980年 | 129篇 |
1979年 | 124篇 |
1978年 | 66篇 |
1977年 | 43篇 |
1976年 | 49篇 |
1975年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
《Fu? & Sprunggelenk》2021,19(2):66-75
The treatment of osteochondral lesions of the talus (OCL) is demanding. Matrix associated techniques are used more and more as a standard, suggestion a more reliable healing. Nevertheless, approaching especially central and medial OCL is still demanding. Medial malleolus osteotomies routineously used, can be a source of morbidity and complications. Improving arthroscopic techniques allow an all-arthroscopic treatment of these defects. 相似文献
994.
ObjectiveTo evaluate the effects of myofascial trigger point release applied to superficial neck muscles and strengthening of the deep flexor muscles in subjects with myofascial temporomandibular disorders (mTMD).MethodsFourteen women (23.4 ± 3.32 years old) presenting with mTMD and trigger points (TrPs) in the sternocleidomastoid, suboccipital, and upper trapezius muscles were included in this study. They were evaluated on two occasions during a baseline period (3 weeks apart) with no intervention and a third time after a 5-weeks intervention protocol. Outcome measures included pressure pain threshold (PPT) over the masticatory muscles, mandibular function, orofacial pain intensity, maximum mouth opening, and the craniocervical flexion test. All women received 10 treatment sessions that included strain-counterstrain technique applied to TrPs found in the prior listed superficial neck muscles and stabilization exercise using a pressure biofeedback for the deep neck flexor muscles. One-way ANOVA or correspondent non-parametric tests as well as effects sizes were used to compare the outcomes at baseline and after the treatment.ResultsStatistically significant improvements were found in the PPT over left masseter and temporalis (p < 0.05) (mean difference (MD) of 0.50 and 0.42 kg/cm2), orofacial pain intensity (MD = −3.39 points), mandibular function (MD = −7.22 points) and performance of the deep cervical muscles (MD = 130.42 points) compared to baseline period. Effect sizes were moderate or large.ConclusionThe protocol intervention may have positive effects in patients with mTMD. However, studies with better methodological quality need to be performed to confirm those effects.Registrationensaiosclinicos.gov.br (RBR-7x828q); 相似文献
995.
996.
Thierry Tiendrebeogo Eugne Messou Shino Arikawa Didier K Ekouevi Aristophane Tanon Vivian Kwaghe Eric Balestre Marcel Djimon Zannou Armel Poda Franois Dabis Antoine Jaquet Albert Minga Renaud Becquet IeDEA West Africa Collaboration 《Journal of the International AIDS Society》2021,24(5)
IntroductionSex differences have already been reported in sub‐Saharan Africa for attrition and immunological response after antiretroviral therapy (ART) initiation, but follow‐up was usually limited to the first two to three years after ART initiation. We evaluated sex differences on the same outcomes in the 10 years following ART initiation in West African adults.MethodsWe used cohort data of patients included in the IeDEA West Africa collaboration, who initiated ART between 2002 and 2014. We modelled no‐follow‐up and 10‐year attrition risks, and immunological response by sex using logistic regression analysis, survival analysis with random effect and linear mixed models respectively.ResultsA total of 71,283 patients (65.8% women) contributed to 310,007 person‐years of follow‐up in 16 clinics in eight West African countries. The cumulative attrition incidence at 10‐year after ART initiation reached 75% and 68% for men and women respectively. Being male was associated with an increased risk of no follow‐up after starting ART (5.1% vs. 4.0%, adjusted Odds Ratio: 1.25 [95% CI: 1.15 to 1.35]) and of 10‐year attrition throughout the 10‐year period following ART initiation: adjusted Hazard Ratios were 1.22 [95% CI: 1.17 to 1.27], 1.08 [95% CI: 1.04 to 1.12] and 1.04 [95% CI: 1.01 to 1.08] during year 1, years 2 to 4 and 5 to 10 respectively. A better immunological response was achieved by women than men: monthly CD4 gain was 30.2 and 28.3 cells/mL in the first four months and 2.6 and 1.9 cells/μL thereafter. Ultimately, women reached the average threshold of 500 CD4 cells/μL in their sixth year of follow‐up, whereas men failed to reach it even at the end of the 10‐year follow‐up period. The proportion of patients reaching the threshold was much higher in women than in men after 10 years since ART initiation (65% vs. 44%).ConclusionsIn West Africa, attrition is unacceptably high in both sexes. Men are more vulnerable than women on both attrition and immunological response to ART in the 10 years following ART initiation. Innovative tracing strategies that are sex‐adapted are needed for patients in care to monitor attrition, detect early high‐risk groups so that they can stay in care with a durably controlled infection. 相似文献
997.
IntroductionKaposi’s sarcoma (KS) remains the most frequent malignancy in persons living with HIV (PWH) in Latin America. We examined KS trends and outcomes from Latin American clinical sites in the era of increased access to antiretroviral therapy (ART).MethodsCohorts in Brazil, Peru, Mexico, Honduras, Argentina and Chile contributed clinical data of PWH ≥16 years old from 2000 to 2017, excluding patients with KS diagnosed before clinic enrolment. We compared KS incidence over time using multivariable incidence rate ratios. Predictors of KS before/at or after ART initiation and of mortality after KS were examined using Cox regression.ResultsOf 25 981 PWH, 481 had incident KS, including 200 ART‐naïve and 281 ART‐treated patients. From 2000 to 2017, the incidence of KS decreased from 55.1 to 3.0 per 1000 person‐years. In models adjusting for CD4 and other factors, the relative risk for KS decreased from 2000 to 2008. Since 2010, the adjusted risk of KS increased in the periods before and ≤90 days after ART initiation but decreased >90 days after ART. In addition to low CD4 and male‐to‐male sex, KS risk after ART was associated with age and history of other AIDS‐defining illnesses. Mortality after KS (approximately 25% after five years) was not associated with either year of KS diagnosis nor timing of diagnosis relative to ART initiation.ConclusionsKS incidence in Latin America has remained stable in recent years and risk is highest before and shortly after ART initiation. Early diagnosis of HIV and ART initiation remain critical priorities in the region. 相似文献
998.
999.
目的 分析2005-2019年江苏省抗病毒治疗的HIV/AIDS的HBV感染情况。方法 采用回顾性资料分析,研究对象来源于中国疾病预防控制信息系统艾滋病防治基本信息系统江苏省2005-2019年HIV/AIDS首次入组抗病毒治疗数据库,采用SPSS 16.0软件进行统计学分析。分析不同特征HIV/AIDS的HBsAg检测率和HBsAg阳性率的差异及其影响因素,单因素分析采用χ2检验,多因素分析采用非条件logistic回归模型。结果 2005-2019年江苏省首次入组抗病毒治疗的HIV/AIDS共29 288例,总体HBsAg检测率为49.8%(14 594/29 288),2005-2019年HBsAg检测率由0.0%(0/80)增加到75.2%(3 448/4 586),呈逐年上升趋势。进行HBsAg检测的HIV/AIDS中,江苏省籍占81.6%(11 915/14 594),男女性别比7.34:1(12 845:1 749),年龄(38.5±13.8)岁,汉族占96.1%(14 023/14 594),已婚/同居占48.9%(7 131/14 594)。男男性传播和异性性传播感染途径占97.9%(14 294/14 594)。logistic回归分析结果显示,HBsAg检测率的影响因素中,2015年及以后入组、外省户籍、已婚/同居、大专及以上文化程度、注射吸毒感染途径的人群HBsAg检测率较高。HIV/AIDS的HBsAg阳性率为8.6%(95%CI:8.2%~9.1%),HBsAg阳性率在2016年之前均>10.0%,自2016年以后稳定在6.7%~8.2%。HBsAg阳性率的影响因素中,2015年及以后入组、女性、年龄>59岁、大专及以上学历人群的HBsAg阳性率较低,而45~59岁年龄组和少数民族人群的HBsAg阳性率较高。结论 2005-2019年江苏省首次入组抗病毒治疗的HIV/AIDS中,HBsAg检测率总体不高,合并HBV感染高于一般人群,需要加强其HBsAg相关检测工作。 相似文献
1000.
Lucie Bryndová Michal Bar Roman Herzig Robert Mikulík Jiří Neumann Daniel Šaňák Ondřej Škoda David Školoudík Daniel Václavík Aleš Tomek 《Health policy (Amsterdam, Netherlands)》2021,125(4):520-525
This article describes policy processes that have led to the re-organisation of stroke care in the Czech Republic since 2011, which has been part of a broader process of care concentration in several medical fields. Currently, stroke care is provided by 13 Comprehensive and 32 Primary Stroke Centres. The paper explains factors that supported the reform implementation, reviews implications, and discusses future challenges.Mandatory reporting of quality indicators, the introduction of a benchmarking system, integration with pre-hospital emergency care, and the introduction of countrywide patient triage have supported more timely treatment for stroke patients and better quality of care. Data from the Stroke Care Quality Indicators of the Czech Stroke Society show positive trends in many areas: the number of patients treated with intravenous thrombolysis quadrupled in eight years, with 26.4 % of all acute stroke patients receiving thrombolysis in 2018. Czech Republic now ranks third in Europe in the number of thrombolysis per population and second in the number of mechanical thrombectomies per population. The Czech experience provides an example of positive outcomes of concentrated stroke care, while highlighting the importance of proper implementation processes. In particular, it is essential to involve stakeholders and to provide reputational incentives through continuous benchmarking. 相似文献